Stromal expression of neutrophil gelatinase-associated lipocalin correlates with poor differentiation and adverse prognosis in oral squamous cell carcinoma

Histopathology

Volumn 64, Issue 3, 2014, Pages 356-364

  Shinriki, Satoru ^a   Jono, Hirofumi ^b,c   Ueda, Mitsuharu ^a   Obayashi, Konen ^c   Nakamura, Takuya ^a   Ota, Kazutoshi ^a   Ota, Tomoko ^a   Sueyoshi, Takanao ^a   Guo, Jianying ^a   Hayashi, Mitsuhiro ^a   Hiraki, Akimitsu ^a   Nakayama, Hideki ^a   Yamashita, Satoshi ^a   Shinohara, Masanori ^a   Ando, Yukio ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Neutrophil gelatinase associated lipocalin; Oral squamous cell carcinoma; Tumour cell differentiation

Indexed keywords

MYELOPEROXIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ARTICLE; CANCER CELL; CANCER PROGNOSIS; CANCER SIZE; CANCER TISSUE; CELL DIFFERENTIATION; CELL INFILTRATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STROMA CELL;

NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN; ORAL SQUAMOUS CELL CARCINOMA; TUMOUR CELL DIFFERENTIATION;

ACUTE-PHASE PROTEINS; AGED; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOCALINS; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; MOUTH NEOPLASMS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; STROMAL CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 84892436087     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12293     Document Type: Article

References (34)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2006. CA Cancer J. Clin. 2006; 56; 106-130.
2. Forastiere AA, Goepfert H, Maor M et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N. Engl. J. Med. 2003; 349; 2091-2098.
3. Kowalski LP, Medina JE. Nodal metastases: predictive factors. Otolaryngol. Clin. North Am. 1998; 31; 621-637.
4. Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature 2005; 438; 946-953.
5. Kademani D, Bell RB, Bagheri S et al. Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade. J. Oral Maxillofac. Surg. 2005; 63; 1599-1605.
6. Lindenblatt Rde C, Martinez GL, Silva LE et al. Oral squamous cell carcinoma grading systems - analysis of the best survival predictor. J. Oral Pathol. Med. 2012; 41; 34-39.
7. Chakraborty S, Kaur S, Guha S, Batra SK. The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. Biochim. Biophys. Acta 2012; 1826; 129-169.
8. Goetz DH, Holmes MA, Borregaard N et al. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol. Cell 2002; 10; 1033-1043.
9. Yang J, Goetz D, Li JY et al. An iron delivery pathway mediated by a lipocalin. Mol. Cell 2002; 10; 1045-1056.
10. Devireddy LR, Gazin C, Zhu X, Green MR. A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell 2005; 123; 1293-1305.
11. Xu S, Venge P. Lipocalins as biochemical markers of disease. Biochim. Biophys. Acta 2000; 1482; 298-307.
12. Hung YC, Huang GS, Lin LW, Hong MY, Se PS. Thea sinensis melanin prevents cisplatin-induced nephrotoxicity in mice. Food Chem. Toxicol. 2007; 45; 1123-1130.
13. Mori K, Lee HT, Rapoport D et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J. Clin. Invest. 2005; 115; 610-621.
14. Bauer M, Eickhoff JC, Gould MN et al. Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer. Breast Cancer Res. Treat. 2008; 108; 389-397.
15. Iannetti A, Pacifico F, Acquaviva R et al. The neutrophil gelatinase-associated lipocalin (NGAL), a NF-κB-regulated gene, is a survival factor for thyroid neoplastic cells. Proc. Natl Acad. Sci. USA 2008; 105; 14058-14063.
16. Kubben FJ, Sier CF, Hawinkels LJ et al. Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer. Eur. J. Cancer 2007; 43; 1869-1876.
17. Zhang H, Xu L, Xiao D et al. Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion. J. Clin. Pathol. 2007; 60; 555-561.
18. Liu MF, Jin T, Shen JH et al. NGAL and NGALR are frequently overexpressed in human gliomas and are associated with clinical prognosis. J. Neurooncol. 2011; 104; 119-127.
19. Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 7th ed. New York, NY: John Wiley & Sons, 2009.
20. Klebanoff SJ. Myeloperoxidase: friend and foe. J. Leukoc. Biol. 2005; 77; 598-625.
21. Hiromoto T, Noguchi K, Yamamura M et al. Up-regulation of neutrophil gelatinase-associated lipocalin in oral squamous cell carcinoma: relation to cell differentiation. Oncol. Rep. 2011; 26; 1415-1421.
22. Seo EY, Lee WH, Piao YJ et al. Identification of calcium-inducible genes in primary keratinocytes using suppression-subtractive hybridization. Exp. Dermatol. 2004; 13; 163-169.
23. Mallbris L, O'Brien KP, Hulthén A et al. Neutrophil gelatinase-associated lipocalin is a marker for dysregulated keratinocyte differentiation in human skin. Exp. Dermatol. 2002; 11; 584-591.
24. Seo SJ, Ahn JY, Hong CK et al. Expression of neutrophil gelatinase-associated lipocalin in skin epidermis. J. Invest. Dermatol. 2006; 126; 510-512.
25. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144; 646-674.
26. Le Cabec V, Cowland JB, Calafat J, Borregaard N. Targeting of proteins to granule subsets is determined by timing and not by sorting: the specific granule protein NGAL is localized to azurophil granules when expressed in HL-60 cells. Proc. Natl Acad. Sci. USA 1996; 93; 6454-6457.
27. Le Cabec V, Calafat J, Borregaard N. Sorting of the specific granule protein, NGAL, during granulocytic maturation of HL-60 cells. Blood 1997; 89; 2113-2121.
28. Kjeldsen L, Cowland JB, Borregaard N. Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse. Biochim. Biophys. Acta 2000; 1482; 272-283.
29. Borregaard N, Sørensen OE, Theilgaard-Mönch K. Neutrophil granules: a library of innate immunity proteins. Trends Immunol. 2007; 28; 340-345.
30. Schmidt-Ott KM, Mori K, Li JY et al. Dual action of neutrophil gelatinase-associated lipocalin. J. Am. Soc. Nephrol. 2007; 18; 407-413.
31. Kehrer JP. Lipocalin-2: pro- or anti-apoptotic? Cell Biol. Toxicol. 2010; 26; 83-89.
32. Shi H, Gu Y, Yang J et al. Lipocalin 2 promotes lung metastasis of murine breast cancer cells. J. Exp. Clin. Cancer Res. 2008; 27; 83.
33. Leng X, Lin H, Ding T et al. Lipocalin 2 is required for BCR-ABL-induced tumorigenesis. Oncogene 2008; 27; 6110-6119.
34. Flo TH, Smith KD, Sato S et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004; 432; 917-921.